Back to search

Article

Effect of HVEM/CD160 Variations on the Clear Cell Renal Carcinoma Risk and Overall Survival

2024-05-30

Abstract excerpt

Renal cell carcinoma (RCC) accounts for approximately 90-95% of all kidney cancers in adults, with the clear cell RCC (ccRCC) the most frequently identified subtype. RCC is known for its responsiveness to immunotherapy, making it an area of significant research interest. Immune checkpoint (IC) molecules, which regulate immune surveillance, are established therapeutic targets in RCC. The aim of this study was to an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c22f47b8-689d-5cf6-bff0-bc88824cac78
DOI
10.20944/preprints202405.1984.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effect of HVEM/CD160 Variations on the Clear Cell Renal Carcinoma Risk and Overall SurvivalDOI 10.20944/preprints202405.1984.v1
Select a neighboring publication to make it the new centre.